Eluciderm develops a topically administered product that facilitates scarless wound healing by reducing dermal fibrosis.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Eluciderm — Funding & Investors." VCBacked, April 26, 2022, https://www.vcbacked.co/company/eluciderm. Accessed July 3, 2026.
VCBacked. (2022). Eluciderm — Funding & Investors. Retrieved July 3, 2026, from https://www.vcbacked.co/company/eluciderm
{{cite web |title=Eluciderm — Funding & Investors |url=https://www.vcbacked.co/company/eluciderm |website=VCBacked |access-date=July 3, 2026}}Profile data sourced and verified per the VCBacked methodology. Last funding round dated .